CVS Health (MEX:CVS) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CVS CVS Health Corp MEX:CVS
72 GF Score
Price MXN1,535.00
GF Value MXN1,349.09
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is CVS Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

CVS Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was MXN67,658 Mil. CVS Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was MXN1,265,694 Mil. CVS Health's annualized EBITDA for the quarter that ended in Jun. 2026 was MXN407,743 Mil. CVS Health's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 3.27.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for CVS Health's Debt-to-EBITDA or its related term are showing as below:

MEX:CVS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.26   Med: 5.2   Max: 10.89
Current: 5.69

During the past 13 years, the highest Debt-to-EBITDA Ratio of CVS Health was 10.89. The lowest was 2.26. And the median was 5.20.

MEX:CVS's Debt-to-EBITDA is ranked worse than
92.31% of 13 companies
in the Healthcare Plans industry
Industry Median: 2.86 vs MEX:CVS: 5.69

CVS Health  (MEX:CVS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

CVS Health Debt-to-EBITDA Related Terms

CVS Health Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for CVS Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health Debt-to-EBITDA Chart

CVS Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CVS Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MEX:CVS vs ELV, CI, HUM: Debt-to-EBITDA Comparison

For the Healthcare Plans subindustry, CVS Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CVS Health Debt-to-EBITDA vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CVS Health's Debt-to-EBITDA falls into.


MEX:CVS
72GF Score
CVS Health Corp MEX:CVS
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

CVS Health's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(104370.9975 + 1333090.0275) / 188893.28925
=7.61

CVS Health's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(67658.36 + 1265693.6075) / 407743.38145456
=3.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is CVS Health (MEX:CVS) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of MXN1,535.00 is trading 13.8% above its estimated GF Value™ of MXN1,349.09. GuruFocus considers CVS Health to be Modestly Overvalued.

Key valuation signals for MEX:CVS:

  • Debt-to-EBITDA:
  • GF Value™: MXN1,349.09 vs. price of MXN1,535.00 (13.8% above fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the MEX:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
72GF Score

Get the complete analysis for MEX:CVS

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,535.00
Price
MXN1,349.09
GF Value